本研究针对当前空间组学建模中细胞分子特征与空间背景信息相互混淆的难题，开发了基于Transformer架构的DECIPHER模型。该模型通过创新性跨尺度对比学习策略，首次实现细胞内（分子身份）与细胞外（空间环境）表征的解耦，在Xenium乳腺癌和MERFISH脑数据集上 ...

Currently, there are multiple commercially available RNA-based biomarkers that are Medicare approved and suggested for use by the National Comprehensive Cancer Network guidelines. There is uncertainty ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting the Decipher ® Prostate Biopsy genomic classifier (GC) may help guide treatment ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

Decipher test scores are independently associated with biopsy upgrades in men on active surveillance for Gleason grade group 1 prostate cancer. Higher Decipher scores on the initial test are ...

Can Genomic Data Guide the Postoperative Management of Prostate Cancer? Finally, observing the primary end point of metastasis may have been subject to ascertainment bias. 14 Specifically, whereas ...

Comparative effectiveness of a patient-centered prostate biopsy report in clinical prostate cancer practice. This is an ASCO Meeting Abstract from the 2018 Genitourinary Cancers Symposium. This ...

The Algorand Foundation revealed the agenda for its second annual Decipher conference today, featuring leading thinkers, builders and founders from across the blockchain landscape. Decipher is to be ...

Imagine having increased muscle weakness for two years before figuring out the cause. That is the shared experience of myasthenia gravis patients. Canadian startup Decipher MedTech is developing a ...